Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA methyltransferase inhibitor exposure-response: Challenges and opportunities. | Clin Transl Sci | 2023 | 37345219 | PubTator, text mining | PubMed |
| Construction and verification of atopic dermatitis diagnostic model based on pyroptosis related biological markers using machine learning methods. | BMC Med Genomics | 2023 | 37330465 | PubTator, text mining | PubMed |
| Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation. | Int J Biol Sci | 2023 | 37324940 | PubTator, text mining | PubMed |
| Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol. | Cancers (Basel) | 2023 | 37297025 | PubTator, text mining | PubMed |
| Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling. | JCI Insight | 2023 | 37288658 | PubTator, text mining | PubMed |
| Assembly Characterization of Human Equilibrium Nucleoside Transporter 1 (hENT1) by Inhibitor Probe-Based dSTORM Imaging. | Anal Chem | 2023 | 37276019 | PubTator, text mining | PubMed |
| The circadian clock is disrupted in pancreatic cancer. | PLoS Genet | 2023 | 37262074 | PubTator, text mining | PubMed |
| Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies. | Pharmaceuticals (Basel) | 2023 | 37259306 | PubTator, text mining | PubMed |
| Neopterin, the Cell-Mediated Immune Response Biomarker, in Inflammatory Periodontal Diseases: A Narrative Review of a More than Fifty Years Old Biomarker. | Biomedicines | 2023 | 37238968 | PubTator, text mining | PubMed |
| Visualization research on ENT1/NIS dual-function gene therapy to reverse drug resistance mediated by MUC1 in GEM-resistant pancreatic cancer. | Nucl Med Biol | 2023 | 37229950 | PubTator, text mining | PubMed |
| Oncolytic herpes simplex virus armed with a bacterial GBP1 degrader improves antitumor activity. | Mol Ther Oncolytics | 2023 | 37223114 | PubTator, text mining | PubMed |
| Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma. | J Gastrointest Oncol | 2023 | 37201091 | PubTator, text mining | PubMed |
| Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. | ACS Med Chem Lett | 2023 | 37197460 | PubTator, text mining | PubMed |
| Combination of Tissue Microarray Profiling and Multiplexed IHC Approaches to Investigate Transport Mechanism of Nucleoside Analog Drug Resistance. | Methods Mol Biol | 2023 | 37191793 | PubTator, text mining | PubMed |
| The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. | Front Immunol | 2023 | 37187740 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection dysregulates the expression of clinically relevant drug metabolizing enzymes in Vero E6 cells and membrane transporters in human lung tissues. | Front Pharmacol | 2023 | 37180730 | PubTator, text mining | PubMed |
| Modeling the Crack Interference in X80 Oil and Gas Pipeline Weld. | Materials (Basel) | 2023 | 37176211 | PubTator, text mining | PubMed |
| A Systematic Review of the Role of Purinergic Signalling Pathway in the Treatment of COVID-19. | Int J Mol Sci | 2023 | 37175571 | PubTator, text mining | PubMed |
| Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy. | Cancers (Basel) | 2023 | 37173915 | PubTator, text mining | PubMed |
| Fluorinated carbohydrates for 18F-positron emission tomography (PET). | Chem Soc Rev | 2023 | 37171037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=11